Table 2.
IC90, IC50 and IC10 of several glioma cell lines and normal glia cells treated with MJ-66 at 48 h.
| IC90 (µM) | IC50 (µM) | IC10 (µM) | |
|---|---|---|---|
| C6 | >1 | 0.06 ± 0.015 | 0.02 ± 0.010 |
| U87 | >1 | 0.05 ± 0.013 | 0.02 ± 0.009 |
| RT2 | >1 | 0.04 ± 0.004 | 0.01 ± 0.001 |
| U373 | >1 | 0.06 ± 0.024 | 0.02 ± 0.008 |
| U251 | >1 | 0.08 ± 0.006 | 0.02 ± 0.013 |
| T98G | >1 | 0.05 ± 0.005 | 0.01 ± 0.004 |
| SVGP12 | >1 | 0.06 ± 0.002 | 0.03 ± 0.006 |
| Glia | >1 | 0.04 ± 0.010 | 0.01 ± 0.006 |
IC90 represents the inhibitory concentration that reduces 90% cell survival; IC50 represents the inhibitory concentration that reduces 50% cell survival; IC10 represents the inhibitory concentration that reduces 10% cell survival.